<VariationArchive VariationID="931891" VariationName="NM_004183.4(BEST1):c.1444del (p.Glu482fs)" VariationType="Deletion" Accession="VCV000931891" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-08" DateCreated="2020-07-04" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="919373" VariationID="931891">
      <GeneList>
        <Gene Symbol="BEST1" FullName="bestrophin 1" GeneID="7439" HGNC_ID="HGNC:12703" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="61949821" stop="61965515" display_start="61949821" display_stop="61965515" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="61717355" stop="61731934" display_start="61717355" display_stop="61731934" Strand="+" />
          </Location>
          <OMIM>607854</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004183.4(BEST1):c.1444del (p.Glu482fs)</Name>
      <CanonicalSPDI>NC_000011.10:61962597:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="61962598" stop="61962598" display_start="61962598" display_stop="61962598" variantLength="1" positionVCF="61962597" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="61730070" stop="61730070" display_start="61730070" display_stop="61730070" variantLength="1" positionVCF="61730069" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>E376fs</ProteinChange>
      <ProteinChange>E422fs</ProteinChange>
      <ProteinChange>E158fs</ProteinChange>
      <ProteinChange>E395fs</ProteinChange>
      <ProteinChange>E482fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004183.4" sequenceAccession="NM_004183" sequenceVersion="4" change="c.1444del" MANESelect="true">
            <Expression>NM_004183.4:c.1444del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004174.1" sequenceAccession="NP_004174" sequenceVersion="1" change="p.Glu482fs">
            <Expression>NP_004174.1:p.Glu482fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.61962598del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.61962598del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.61730070del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.61730070del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008346.1" sequenceAccession="NG_008346" sequenceVersion="1" change="g.10063del">
            <Expression>NG_008346.1:g.10063del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009033.1" sequenceAccession="NG_009033" sequenceVersion="1" change="g.17715del">
            <Expression>NG_009033.1:g.17715del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001139443.2" sequenceAccession="NM_001139443" sequenceVersion="2" change="c.1264del">
            <Expression>NM_001139443.2:c.1264del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001132915.1" sequenceAccession="NP_001132915" sequenceVersion="1" change="p.Glu422fs">
            <Expression>NP_001132915.1:p.Glu422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300786.2" sequenceAccession="NM_001300786" sequenceVersion="2" change="c.1183del">
            <Expression>NM_001300786.2:c.1183del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287715.1" sequenceAccession="NP_001287715" sequenceVersion="1" change="p.Glu395fs">
            <Expression>NP_001287715.1:p.Glu395fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300787.2" sequenceAccession="NM_001300787" sequenceVersion="2" change="c.1264del">
            <Expression>NM_001300787.2:c.1264del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287716.1" sequenceAccession="NP_001287716" sequenceVersion="1" change="p.Glu422fs">
            <Expression>NP_001287716.1:p.Glu422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363591.2" sequenceAccession="NM_001363591" sequenceVersion="2" change="c.1126del">
            <Expression>NM_001363591.2:c.1126del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350520.1" sequenceAccession="NP_001350520" sequenceVersion="1" change="p.Glu376fs">
            <Expression>NP_001350520.1:p.Glu376fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363592.1" sequenceAccession="NM_001363592" sequenceVersion="1" change="c.*339del">
            <Expression>NM_001363592.1:c.*339del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363593.2" sequenceAccession="NM_001363593" sequenceVersion="2" change="c.472del">
            <Expression>NM_001363593.2:c.472del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350522.1" sequenceAccession="NP_001350522" sequenceVersion="1" change="p.Glu158fs">
            <Expression>NP_001350522.1:p.Glu158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_134580.2" sequenceAccession="NR_134580" sequenceVersion="2" change="n.1760del">
            <Expression>NR_134580.2:n.1760del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="759410076" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004183.4(BEST1):c.1444del (p.Glu482fs) AND Vitelliform macular dystrophy 2" Accession="RCV001198877" Version="2">
        <ClassifiedConditionList TraitSetID="696">
          <ClassifiedCondition DB="MedGen" ID="C2745945">Vitelliform macular dystrophy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-15" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004183.4(BEST1):c.1444del (p.Glu482fs) AND not provided" Accession="RCV001388531" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-01-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004183.4(BEST1):c.1444del (p.Glu482fs) AND Autosomal dominant vitreoretinochoroidopathy" Accession="RCV002290633" Version="2">
        <ClassifiedConditionList TraitSetID="701">
          <ClassifiedCondition DB="MedGen" ID="C3888099">Autosomal dominant vitreoretinochoroidopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-02" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-07-04" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21825197</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="701" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6115" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VITREORETINOCHOROIDOPATHY, AUTOSOMAL DOMINANT, WITH NANOPHTHALMOS</ElementValue>
                <XRef Type="MIM" ID="193220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VITREORETINOCHOROIDOPATHY WITH MICROCORNEA, GLAUCOMA, AND CATARACT</ElementValue>
                <XRef Type="MIM" ID="193220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vitreoretinochoroidopathy dominant</ElementValue>
                <XRef ID="Vitreoretinochoroidopathy+dominant/7409" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VRCP autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant vitreoretinochoroidopathy</ElementValue>
                <XRef ID="MONDO:0008662" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ADVIRC</ElementValue>
                <XRef Type="MIM" ID="193220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VRCP</ElementValue>
                <XRef Type="MIM" ID="193220" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5507" />
                <XRef ID="5507" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Bestrophinopathies, the spectrum of ophthalmic disorders caused by pathogenic variants in BEST1, are typically characterized by retinal degeneration. The four recognized phenotypes are the three autosomal dominant disorders: Best vitelliform macular dystrophy (BVMD), BEST1 adult-onset vitelliform macular dystrophy (AVMD), and autosomal dominant vitreoretinochoroidopathy (ADVIRC); and autosomal recessive bestrophinopathy (ARB). Onset is usually in the first decade (except AVMD in which onset is age 30 to 50 years). Slow visual deterioration is the usual course. Choroidal neovascularization can occur in rare cases. ADVIRC is also associated with panophthalmic involvement including nanophthalmos, microcornea, hyperopia, and narrow anterior chamber angle with angle closure glaucoma.</Attribute>
                <XRef ID="NBK1167" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301346</ID>
                <ID Source="BookShelf">NBK1167</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <ID Source="PubMed">22234150</ID>
              </Citation>
              <XRef ID="263347" DB="Orphanet" />
              <XRef ID="3086" DB="Orphanet" />
              <XRef ID="C3888099" DB="MedGen" />
              <XRef ID="MONDO:0008662" DB="MONDO" />
              <XRef Type="MIM" ID="193220" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="696" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2720" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Best vitelliform macular dystrophy, multifocal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vitelliform macular dystrophy 2</ElementValue>
                <XRef ID="MONDO:0007931" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VITELLIFORM MACULAR DYSTROPHY, EARLY-ONSET</ElementValue>
                <XRef Type="MIM" ID="153700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VITELLIFORM MACULAR DYSTROPHY, JUVENILE-ONSET</ElementValue>
                <XRef Type="MIM" ID="153700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Best disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Best macular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Macular degeneration, polymorphic vitelline</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VMD2</ElementValue>
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="153700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BMD</ElementValue>
                <XRef Type="MIM" ID="153700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VMD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="182" />
                <XRef ID="182" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Bestrophinopathies, the spectrum of ophthalmic disorders caused by pathogenic variants in BEST1, are typically characterized by retinal degeneration. The four recognized phenotypes are the three autosomal dominant disorders: Best vitelliform macular dystrophy (BVMD), BEST1 adult-onset vitelliform macular dystrophy (AVMD), and autosomal dominant vitreoretinochoroidopathy (ADVIRC); and autosomal recessive bestrophinopathy (ARB). Onset is usually in the first decade (except AVMD in which onset is age 30 to 50 years). Slow visual deterioration is the usual course. Choroidal neovascularization can occur in rare cases. ADVIRC is also associated with panophthalmic involvement including nanophthalmos, microcornea, hyperopia, and narrow anterior chamber angle with angle closure glaucoma.</Attribute>
                <XRef ID="NBK1167" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301346</ID>
                <ID Source="BookShelf">NBK1167</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <ID Source="PubMed">22234150</ID>
              </Citation>
              <XRef ID="1243" DB="Orphanet" />
              <XRef ID="C2745945" DB="MedGen" />
              <XRef ID="MONDO:0007931" DB="MONDO" />
              <XRef Type="MIM" ID="153700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2697958" SubmissionDate="2020-11-24" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_001139443.1:c.1264delG|OMIM:153700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001369872" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001139443.1:c.1264delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="153700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5043572" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_004183.4:c.1444del|OMIM:193220" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579399" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BEST1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004183.4:c.1444del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193220" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3115200" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11943149|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001589534" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21825197</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in BEST1 are known to be pathogenic (PMID: 21825197). This variant has not been reported in the literature in individuals with BEST1-related conditions. ClinVar contains an entry for this variant (Variation ID: 931891). This variant is present in population databases (rs759410076, ExAC 0.004%). This sequence change creates a premature translational stop signal (p.Glu482Asnfs*14) in the BEST1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BEST1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.61730070del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3115200" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5043572" TraitType="Disease" MappingType="XRef" MappingValue="193220" MappingRef="OMIM">
        <MedGen CUI="C3888099" Name="Autosomal dominant vitreoretinochoroidopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2697958" TraitType="Disease" MappingType="XRef" MappingValue="153700" MappingRef="OMIM">
        <MedGen CUI="C2745945" Name="Vitelliform macular dystrophy 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

